INMB · Inmune Bio, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Given the Company's projected operating requirements and its existing cash and cash equivalents, the Company is projecting insufficient liquidity to sustain its operations through one year following the date that the financial statements are issued. These conditions and events raise substantial doubt about the Company's ability to continue as a going concern. Because management's plans have not yet been finalized and are not within the Company's control, the implementation of such plans cannot be considered probable. As a result, the Company has concluded that management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Positioning
Aug 21, 2026 · 4 days to expiryChain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 0 | — | — | — | — | $0.05 | — | — | 1 | 1 | |
| 1.1k | 88 | 104.5% | 0.76 | $0.20 | — | -0.333 | 531.8% | — | 0 | |
| 167 | 5 | 392.2% | 0.302 | $0.03 | $1.00 | -0.774 | 307.7% | 2 | 2 | |
| 2 | 2 | — | — | $0.50 | — | -0.86 | 409.8% | — | 0 | |
| 0 | — | — | — | — | — | -0.768 | 669.5% | — | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Jul 16, 2026–Aug 14, 2026; 5 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.